HomeALPMY • OTCMKTS
add
Astellas Pharma ADR Representing 1 Ord Shs
Previous close
$16.20
Day range
$16.20 - $16.95
Year range
$8.37 - $16.95
Market cap
4.58T JPY
Avg Volume
120.80K
P/E ratio
-
Dividend yield
-
In the news
Financials
Income Statement
Revenue
Net income
| (JPY) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 571.21B | 10.40% |
Operating expense | 322.26B | -6.32% |
Net income | 100.38B | 202.78% |
Net profit margin | 17.57 | 193.11% |
Earnings per share | — | — |
EBITDA | 183.68B | 45.71% |
Effective tax rate | 25.11% | — |
Balance Sheet
Total assets
Total liabilities
| (JPY) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 254.30B | 41.38% |
Total assets | 3.60T | 4.41% |
Total liabilities | 1.84T | -6.07% |
Total equity | 1.76T | — |
Shares outstanding | 1.79B | — |
Price to book | 0.02 | — |
Return on assets | 9.54% | — |
Return on capital | 13.89% | — |
Cash Flow
Net change in cash
| (JPY) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 100.38B | 202.78% |
Cash from operations | 74.17B | 362.82% |
Cash from investing | -15.78B | 48.64% |
Cash from financing | -90.84B | 12.90% |
Net change in cash | -32.76B | 71.04% |
Free cash flow | 24.10B | 74.28% |
About
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.
Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
Founded
Apr 1, 2005
Headquarters
Website
Employees
13,643
